SCHEMBL1088243

SCHEMBL1088243

CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)Nc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 1/20 0.44
▸ CAPN1 P07384 1/20 0.43
▸ PFKFB1 P16118 6/20 0.43
▸ PFKFB3 Q16875 6/20 0.43
▸ PFKFB2 O60825 5/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ MAPT P10636 2/20 0.41
▸ HPGD P15428 1/20 0.41
▸ HDAC3 O15379 1/20 0.41
▸ HDAC1 Q13547 1/20 0.41
▸ HDAC2 Q92769 1/20 0.41
▸ HDAC10 Q969S8 1/20 0.41
▸ HDAC11 Q96DB2 1/20 0.41
▸ HDAC8 Q9BY41 1/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.41
▸ TERT O14746 1/20 0.41
▸ MEN1 O00255 2/20 0.40
▸ LMNA P02545 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20863893 0.85 PFKFB1 (0.49) CAPN1PFKFB1PFKFB3PFKFB2SMN1; SMN2
SCHEMBL22295666 0.85 PFKFB1 (0.49) CAPN1PFKFB1PFKFB3PFKFB2SMN1; SMN2
SCHEMBL7115295 0.85 HDAC3 (0.44) NAMPTMAPTHDAC3HDAC1HDAC2
SCHEMBL2409615 0.85 NAMPT (0.46) NAMPTSMN1; SMN2MAPTHPGDTERT
SCHEMBL1723853 0.84 CTSC (0.53) SMN1; SMN2MEN1KMT2A
SCHEMBL7761782 0.83 PDF (0.55) NAMPTHDAC3HDAC1HDAC2HDAC10
SCHEMBL10790080 0.82 BCL9 (0.38) PFKFB1PFKFB3PFKFB2SMN1; SMN2MAPT
SCHEMBL10790088 0.82 BCL9 (0.38) PFKFB1PFKFB3PFKFB2SMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL10789634 0.82 HTR2C (0.38) PFKFB1PFKFB3PFKFB2SMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL10790372 0.82 HTR2C (0.38) PFKFB1PFKFB3PFKFB2SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260028557-A1 MUTANT PROTEASE KAO CORPORATION (JP) 2026-01-29 — — US disclosed
WO-2025126951-A1 MODIFIED 5'-UNTRANSLATED REGION AND METHOD FOR PRODUCING TARGET SUBSTANCE USING SAME 花王株式会社 2025-06-19 — — WO disclosed
EP-4563702-A1 MUTANT PROTEASE Kao Corporation (JP) 2025-06-04 — — EP disclosed
US-12319943-B2 Mutant protease KAO CORPORATION (JP) 2025-06-03 — — US disclosed
EP-3470517-B1 ALKALINE PROTEASE VARIANT KAO CORP (JP) 2024-01-10 — — EP disclosed
CN-113557292-B Mutant proteases 花王株式会社 2023-10-20 — — CN disclosed
US-20220154109-A1 Mutant Protease KAO CORPORATION (JP) 2022-05-19 — — US disclosed
CN-109312323-B Mutant alkaline proteases 花王株式会社 2022-03-08 — — CN disclosed
US-8153413-B2 High alkaline protease and use thereof JAPAN AGENCY FOR MARINE-EARTH SCIENCE AND TECHNOLOGY (JP) 2012-04-10 — — US disclosed
EP-1660970-A4 SYSTEMS AND METHODS FOR BIOPOLYMER ENGINEERING DNA TWOPOINTO INC (US) 2007-02-14 — — EP disclosed
EP-1660970-A2 SYSTEMS AND METHODS FOR BIOPOLYMER ENGINEERING DNA TWOPOINTO INC. (US) 2006-05-31 — — EP disclosed
WO-2005013090-A2 SYSTEMS AND METHODS FOR BIOPOLYMER ENGINEERING DNA TWOPOINTO INC. (US) 2005-02-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260028557-A1 MUTANT PROTEASE IDUA, CTRL, ANPEP NAMPT 4799/4885CAPN1 246/4885PFKFB1 4756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback